Document:

Exhibit 10.9

 

 SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 5, 2015, by and between AXIOM CORP.,
a Colorado corporation, with headquarters located  at  380  Vansickle  Road,  Unit  600,  St.  Catharines,  ONT  L2S  0B5  Canada
 (the “Company”), and _____________, a _______________ company, with its address at _____________________(the “Buyer”).

 

WHEREAS:

 

A.
        The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act of 1933, as amended (the “1933 Act”);

 

B.

        Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement
a 10% convertible note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of US$556,250.00
(together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance
with the terms thereof, the “Note”), convertible into shares of common stock, $0.00001 par value per share, of the
Company (the “Common Stock”), upon the terms and subject to the limitations and conditions set forth in such Note.

 

C.

        The Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of Note as is set
forth immediately below its name on the signature pages hereto; and

 

NOW
THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1.            PURCHASE
AND SALE OF NOTE.

 

a.     Purchase  of  Note.  On  the  Closing Date  (as  defined  below),  the Company shall issue and sell to the Buyer and the
Buyer agrees to purchase from the Company, such principal amount of Note as is set forth immediately below the Buyer’s name
on the signature pages hereto, subject to the express terms of the Note.

 

b.     Form
of Payment. On the Closing Date (as defined below), the Buyer shall pay the purchase price for the first tranche of the
Note, which is equal to $230,000.00 (the “First Tranche Purchase Price”) by wire transfer of immediately
available funds, in accordance with the Company’s written wiring instructions, against delivery of the Note, and (i)
the Company shall deliver such duly executed Note, on behalf of the Company, to the Buyer. The Buyer shall fund additional
tranches under the Note, pursuant to the terms and conditions of the Note and in accordance with the Company’s
written wiring instructions.

 

     

     

    

 

c.     Closing Date.  Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section
7 below, the date and time of the issuance and sale of the Note pursuant to this Agreement (the “Closing Date”) shall
be 5:00 P.M., Eastern Standard Time on or about October 5, 2015, or such other mutually agreed upon time.  The closing of the
transactions contemplated by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may
be agreed to by the parties.

 

2.            REPRESENTATIONS
AND WARRANTIES OF THE BUYER.The Buyer represents and warrants to the Company that:

 

a.     Investment Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon
conversion of or otherwise pursuant to the Note (including, without limitation, such additional shares of Common Stock, if any,
as are issuable (i) on account of interest on the Note or (ii) under any other provision in the Note, such shares of Common Stock
being collectively referred to herein as the “Conversion Shares” and, collectively with the Note, the “Securities”)
for its own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered
or exempted from registration under the 1933 Act; provided, however, that by making the representations herein,
the Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to dispose
of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the 1933 Act.

 

b.
    Accredited Investor Status.  The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D (an “Accredited Investor”).

 

c.     Reliance on Exemptions.  The Buyer understands that the Securities are being offered and sold to it in reliance upon specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of the Buyer to acquire the Securities.

 

d.     Information.
The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished
with all materials relating to the business, finances and operations of the Company and materials relating to the offer and
sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been,
and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company.
Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not
disclose such information unless such information is disclosed to the public prior to or promptly following such
disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its
advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations
and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a
significant degree of risk. The Buyer is not aware of any facts that may constitute a breach of any of the Company's
representations and warranties made herein.

 

    	 	2	 

     

    

 

e.     Governmental Review.  The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Securities.

 

f.      Transfer
or Re-sale. The Buyer understands that (i) the sale or re-sale of the Securities has not been and is not being registered
under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a)
the Securities are sold pursuant to an effective registration statement under the 1933 Act, (b) the Buyer shall have
delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form, substance and scope
customary for opinions of counsel in comparable transactions to the effect that the Securities to be sold or transferred may
be sold or transferred pursuant to an exemption from such registration, which opinion shall be accepted by the Company, (c)
the Securities are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated under the 1933 Act
(or a successor rule) (“Rule 144”)) of the Buyer who agrees to sell or otherwise transfer the Securities only in
accordance with this Section 2(f) and who is an Accredited Investor, (d) the Securities are sold pursuant to Rule 144, or (e)
the Securities are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and
the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form,
substance and scope customary for opinions of counsel in corporate transactions, which opinion shall be accepted by the
Company; (ii) any sale of such Securities made in reliance on Rule 144 may be made only in accordance with the terms of said
Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in which the seller (or
the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may
require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii)
neither the Company nor any other person is under any obligation to register such Securities under the 1933 Act or any state
securities laws or to comply with the terms and conditions of any exemption thereunder (in each case). Notwithstanding
the foregoing or anything else contained herein to the contrary, the Securities may be pledged as collateral in connection
with a bona fide margin account or other lending arrangement.

 

    	 	3	 

     

    

 

g.     Legends.
The Buyer understands that the Note and Conversion Shares, until such time as the Conversion Shares have been registered
under the 1933 Act or may be sold pursuant to Rule 144 or Regulation S, or other valid exemption, without any restriction as
to the number of securities as of a particular date that can then be immediately sold, will bear a restrictive
legend in substantially the following form (and a stop-transfer order may be placed against transfer of the certificates for
such Securities):

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL
BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS
SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE
SECURITIES.”

 

The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security
upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for
sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation
S without any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such
holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act,
which opinion shall be accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities,
including those represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus
delivery requirements, if any. In the event that the Company does not accept the opinion of counsel provided by the Buyer with
respect to the transfer of Securities pursuant to an exemption from registration, such as Rule 144 or Regulation S, at the Deadline,
it will be considered an Event of Default pursuant to Section 3.2 of the Note.

 

h.
    Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement
has been duly executed and delivered on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the
Buyer enforceable in accordance with its terms.

 

    	 	4	 

     

    

 

i.      Residency. The Buyer is a resident of the jurisdiction set forth immediately
below the Buyer’s name on the signature pages hereto.

 

3.             REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company represents and warrants to the Buyer that, except as disclosed
in the SEC Documents, that:

 

a.
    Organization and Qualification.  The Company and each of its Subsidiaries (as defined below), if any, is a corporation
duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full
power and authority (corporate and other) to own, lease, use and operate its properties and to carry on its business as and where
now owned, leased, used, operated and conducted.  Schedule 3(a) sets forth a list of all of the Subsidiaries of the Company and
the jurisdiction in which each is incorporated. The Company and each of its Subsidiaries is duly qualified as a foreign corporation
to do business and is in good standing in every jurisdiction in which its ownership or use of property or the nature of the business
conducted by it makes such qualification necessary except where the failure to be so qualified or in good standing would not have
a Material Adverse Effect. “Material Adverse Effect” means any material adverse effect on the business, operations,
assets, financial condition or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions
contemplated hereby or by the agreements or instruments to be entered into in connection herewith.  “Subsidiaries”
means any corporation or other organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly,
any equity or other ownership interest.

 

b.
    Authorization;  Enforcement.  (i)  The  Company  has  all  requisite corporate power and authority to enter into and perform
this Agreement, the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance
with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation
by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance
and reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized
by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative,
and such authorized representative is the true and official representative with authority to sign this Agreement and the other
documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution
and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the
Company enforceable against the Company in accordance with its terms.

 

    	 	5	 

     

    

 

c.
    Capitalization.
Except as disclosed in the SEC Documents (as defined below), no shares are reserved for issuance pursuant to the
Company’s stock option plans, no shares are reserved for issuance pursuant to securities (other than the
Securities) exercisable for, or convertible into or exchangeable for shares of Common Stock. All of such outstanding
shares of capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non- assessable. No
shares of capital stock of the Company are subject to preemptive rights or any other similar rights of the shareholders of
the Company or any liens or encumbrances imposed through the actions or failure to act of the Company. Except as disclosed in
the SEC Documents, as of the effective date of this Agreement, (i) there are no outstanding options, warrants, scrip, rights
to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights of
any character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of capital
stock of the Company or any of its Subsidiaries, or arrangements by which the Company or any of its Subsidiaries is or may
become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries, (ii) there are no
agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of its
or their securities under the 1933 Act and (iii) there are no anti-dilution or price adjustment provisions contained in any
security issued by the Company (or in any agreement providing rights to security holders) that will be triggered by the
issuance of the Note or the Conversion Shares. The Company has filed in its SEC Documents true and correct copies of the
Company’s Certificate of Incorporation as in effect on the date hereof (“Certificate of Incorporation”),
the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities
convertible into or exercisable for Common Stock of the Company and the material rights of the holders thereof in respect
thereto. The Company shall provide the Buyer with a written update of this representation signed by the Company’s Chief
Executive on behalf of the Company as of the Closing Date.

 

d.

    Issuance of Shares.  The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note,
in accordance with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens,
claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights
of shareholders of the Company and will not impose personal liability upon the holder thereof.

 

e.

    Acknowledgment of Dilution.  The Company understands and acknowledges the potentially dilutive effect to the Common Stock
upon the issuance of the Conversion Shares upon conversion of the Note.  The Company further acknowledges that its obligation
to issue Conversion Shares upon conversion of the Note in accordance with this Agreement, the Note is absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

    	 	6	 

     

    

 

f.
     No
Conflicts. The execution, delivery and performance of this Agreement and the Note by the Company and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and
reservation for issuance of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of
the Certificate of Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or
constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to
others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, patent, patent
license or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law,
rule, regulation, order, judgment or decree (including federal and state securities laws and regulations and regulations of
any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or any of its
Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for
such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or
in the aggregate, have a Material Adverse Effect). Neither the Company nor any of its Subsidiaries is in violation of its
Certificate of Incorporation, By-laws or other organizational documents and neither the Company nor any of its Subsidiaries
is in default (and no event has occurred which with notice or lapse of time or both could put the Company or any of its
Subsidiaries in default) under, and neither the Company nor any of its Subsidiaries has taken any action or failed to take
any action that would give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company or any of its Subsidiaries is a party or by which any property or assets of the
Company or any of its Subsidiaries is bound or affected, except for possible defaults as would not, individually or in the
aggregate, have a Material Adverse Effect. The businesses of the Company and its Subsidiaries, if any, are not being
conducted, and shall not be conducted so long as the Buyer owns any of the Securities, in violation of any law, ordinance or
regulation of any governmental entity. Except as specifically contemplated by this Agreement and as required under the 1933
Act and any applicable state securities laws, the Company is not required to obtain any consent, authorization or order of,
or make any filing or registration with, any court, governmental agency, regulatory agency, self-regulatory organization
or stock market or any third party in order for it to execute, deliver or perform any of its obligations under this
Agreement, the Note in accordance with the terms hereof or thereof or to issue and sell the Note in accordance with the terms
hereof and to issue the Conversion Shares upon conversion of the Note. All consents, authorizations, orders, filings and
registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or
prior to the date hereof. The Company is not in violation of the listing requirements of the Over-the- Counter Bulletin Board
(the “OTCBB”), the OTCQB or any similar quotation system, and does not reasonably anticipate that the Common
Stock will be delisted by the OTCBB, the OTCQB or any similar quotation system, in the foreseeable future. The Company and
its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

    	 	7	 

     

    

 

g.
    SEC
Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of
1934, as amended (the “1934 Act”) (all of the foregoing filed prior to the date hereof and all exhibits included
therein and financial statements and schedules thereto and documents (other than exhibits to such documents) incorporated by
reference therein, being hereinafter referred to herein as the “SEC Documents”). The Company has delivered to the
Buyer true and complete copies of the SEC Documents, except for such exhibits and incorporated documents. As of their
respective dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the
rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at
the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended
or updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior the
date hereof). As of their respective dates, the financial statements of the Company included in the SEC Documents complied as
to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles, consistently applied, during the periods involved and fairly present in all material respects the
consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to
normal year-end audit adjustments). Except as set forth in the financial statements of the Company included in the SEC
Documents, the Company has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the
ordinary course of business, and (ii) obligations under contracts and commitments incurred in the ordinary course of business
and not required under generally accepted accounting principles to be reflected in such financial statements, which,
individually or in the aggregate, are not material to the financial condition or operating results of the Company. The
Company is subject to the reporting requirements of the 1934 Act. For the avoidance of doubt, filing of the documents
required in this Section 3(g) via the SEC’s Electronic Data Gathering, Analysis, and Retrieval system
(“EDGAR”) shall satisfy all delivery requirements of this Section 3(g).

 

h.

    Absence of Certain Changes.  There has been no material adverse change and no material adverse development in the assets,
liabilities, business, properties, operations, financial condition, results of operations, prospects or 1934 Act reporting status
of the Company or any of its Subsidiaries.

 

i.

     Absence of Litigation.  There is no action, suit, claim, proceeding, inquiry or investigation before or by any court,
public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its
Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in their
capacity as such, that could have a Material Adverse Effect.  Schedule 3(i) contains a complete list and summary description of
any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its Subsidiaries,
without regard to whether it would have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or
circumstances which might give rise to any of the foregoing.

 

    	 	8	 

     

    

 

j.
     Patents, Copyrights, etc.  The Company and each of its Subsidiaries owns or possesses the requisite licenses or rights
to use all patents, patent applications, patent rights, inventions, know-how, trade secrets, trademarks, trademark applications,
service marks, service names, trade names and copyrights (“Intellectual Property”) necessary to enable it to conduct
its business as now operated (and, as presently contemplated to be operated in the future); Except as disclosed in the SEC Documents,
there is no claim or action by any person pertaining to, or proceeding pending, or to the Company’s knowledge threatened,
which challenges the right of the Company or of a Subsidiary with respect to any Intellectual Property necessary to enable it
to conduct its business as now operated (and, as presently contemplated to be operated in the future); to the best of the Company’s
knowledge, the Company’s or its Subsidiaries’ current and intended products, services and processes do not infringe
on any Intellectual Property or other rights held by any person; and the Company is unaware of any facts or circumstances which
might give rise to any of the foregoing. The Company and each of its Subsidiaries have taken reasonable security measures to protect
the secrecy, confidentiality and value of their Intellectual Property.

 

k.

    No Materially Adverse Contracts, Etc.  Neither the Company nor any of its Subsidiaries is subject to any charter, corporate
or other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company’s officers
has or is expected in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party
to any contract or agreement which in the judgment of the Company’s officers has or is expected to have a Material Adverse
Effect.

 

l.
    
 Tax Status. The Company and each of its Subsidiaries has made or filed all federal, state and foreign income and all other
tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that
the Company and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid
and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown
or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside
on its books provisions reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns,
reports or declarations apply.  There are no unpaid taxes in any material amount claimed to be due by the taxing authority of
any jurisdiction, and the officers of the Company know of no basis for any such claim.  The Company has not executed a waiver
with respect to the statute of limitations relating to the assessment or collection of any foreign, federal, state or local tax.
None of the Company’s tax returns is presently being audited by any taxing authority.

 

m.
    Certain
Transactions. Except for arm’s length transactions pursuant to which the Company or any of its Subsidiaries makes
payments in the ordinary course of business upon terms no less favorable than the Company or any of its Subsidiaries
could obtain from third parties and other than the grant of stock options disclosed on Schedule 3(c), none of the officers,
directors, or employees of the Company is presently a party to any transaction with the Company or any of its Subsidiaries
(other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any corporation,
partnership, trust or other entity in which any officer, director, or any such employee has a substantial interest or is an
officer, director, trustee or partner.

 

    	 	9	 

     

    

 

n.
    Disclosure.
All information relating to or concerning the Company or any of its Subsidiaries set forth in this Agreement and provided to
the Buyer pursuant to Section 2(d) hereof and otherwise in connection with the transactions contemplated hereby is true and
correct in all material respects and the Company has not omitted to state any material fact necessary in order to make the
statements made herein or therein, in light of the circumstances under which they were made, not misleading. No event or
circumstance has occurred or exists with respect to the Company or any of its Subsidiaries or its or their business,
properties, prospects, operations or financial conditions, which, under applicable law, rule or regulation, requires public
disclosure or announcement by the Company but which has not been so publicly announced or disclosed (assuming for this
purpose that the Company’s reports filed under the 1934 Act are being incorporated into an effective registration
statement filed by the Company under the 1933 Act).

 

o.

    Acknowledgment  Regarding  Buyer’  P urch ase  of  S ecurit ies  .  The Company acknowledges and agrees that the
Buyer is acting solely in the capacity of arm’s length purchasers  with  respect  to  this  Agreement  and  the  transactions
 contemplated  hereby.  The Company further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the
Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any statement
made by the Buyer or any of its respective representatives or agents in connection with this Agreement and the transactions contemplated
hereby is not advice or a recommendation and is merely incidental to the Buyer’ purchase of the Securities. The Company
further represents to the Buyer that the Company’s decision to enter into this Agreement has been based solely on the independent
evaluation of the Company and its representatives.

 

p.

    No Integrated Offering.  Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf,
has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances
that would require registration under the 1933 Act of the issuance of the Securities to the Buyer.  The issuance of the Securities
to the Buyer will not be integrated with any other issuance of the Company’s securities (past, current or future) for purposes
of any shareholder approval provisions applicable to the Company or its securities.

 

q.

    No Brokers.  The Company has taken no action which would give rise to any claim by any person for brokerage commissions,
transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby, other than as provided
for in the disbursement memo.

 

    	 	10	 

     

    

 

r.

    Permits; Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations,
licenses, permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and
operate its properties and to carry on its business as it is now being conducted (collectively, the “Company Permits”),
and there is no action pending or, to the knowledge of the Company, threatened regarding suspension or cancellation of any of
the Company Permits. Neither the Company nor any of its Subsidiaries is in conflict with, or in default or violation of, any of
the Company Permits, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not
reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries has received any notification
with respect to possible conflicts, defaults or violations of applicable laws, except for notices relating to possible conflicts,
defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.

 

s.
    Environmental
Matters.

 

(i)

       There are, to the Company’s knowledge, with respect to the Company or any of its Subsidiaries or any predecessor of the
Company, no past or present violations of Environmental Laws (as defined below), releases of any material into the environment,
actions, activities, circumstances, conditions, events, incidents, or contractual obligations which may give rise to any common
law environmental liability or any liability under the Comprehensive Environmental Response, Compensation and Liability Act of
1980 or similar federal, state, local or foreign laws and neither the Company nor any of its Subsidiaries has received any notice
with respect to any of the foregoing, nor is any action pending or, to the Company’s knowledge, threatened in connection
with any of the foregoing. The term “Environmental Laws” means all federal, state, local or foreign laws relating
to pollution or protection  of human  health  or the  environment  (including,  without  limitation,  ambient  air, surface water,
groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases
or threatened releases of chemicals, pollutants contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage,
disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters,
injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated
or approved thereunder.

 

(ii)

      Other than those that are or were stored, used or disposed of in compliance with applicable law, no Hazardous Materials are
contained on or about any real property currently owned, leased or used by the Company or any of its Subsidiaries, and no
Hazardous Materials were released on or about any real property previously owned, leased or used by the Company or any of its
Subsidiaries during the period the property was owned, leased or used by the Company or any of its Subsidiaries, except in
the normal course of the Company’s or any of its Subsidiaries’ business.

 

    	 	11	 

     

    

 

(iii)

     There are no underground storage tanks on or under any real property owned, leased or used by the Company or any of its Subsidiaries
that are not in compliance with applicable law.

 

t.
    
 Title to Property.  Except as disclosed in the SEC Documents the Company and its Subsidiaries have good and marketable
title in fee simple to all real property and good and marketable title to all personal property owned by them which is material
to the business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects or such
as would not have a Material Adverse Effect. Any real property and facilities held under lease by the Company and its Subsidiaries
are held by them under valid, subsisting and enforceable leases with such exceptions as would not have a Material Adverse Effect.

 

u.

    Internal Accounting Controls.  Except as disclosed in the SEC Documents the Company and each of its Subsidiaries maintain
a system of internal accounting controls sufficient, in the judgment of the Company’s board of directors, to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or
specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.

 

v.

    Foreign Corrupt Practices.  Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee
or other person acting on behalf of the Company or any Subsidiary has, in the course of his actions for, or on behalf of, the
Company, used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political
activity; made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate
funds; violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any
bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or
employee.

 

w.
  Solvency.
The Company (after giving effect to the transactions contemplated by this Agreement) is solvent (i.e., its assets have
a fair market value in excess of the amount required to pay its probable liabilities on its existing debts as they become
absolute and matured) and currently the Company has no information that would lead it to reasonably conclude that the Company
would not, after giving effect to the transaction contemplated by this Agreement, have the ability to, nor does it intend to
take any action that would impair its ability to, pay its debts from time to time incurred in connection therewith as
such debts mature. The Company did not receive a qualified opinion from its auditors with respect to its most recent
fiscal year end and, after giving effect to the transactions contemplated by this Agreement, does not anticipate or know of
any basis upon which its auditors might issue a qualified opinion in respect of its current fiscal year. For the avoidance of
doubt any disclosure of the Borrower’s ability to continue as a “going concern” shall not, by itself, be a
violation of this Section 3(w).

 

    	 	12	 

     

    

 

x.
    No Investment Company.  The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.

 

y.
    Insurance.  The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has any reason to believe that
it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. Upon written
request the Company will provide to the Buyer true and correct copies of all policies relating to directors’ and officers’
liability coverage, errors and omissions coverage, and commercial general liability coverage.

 

z.
     Breach of Representations and Warranties by the Company.  If the Company breaches any of the representations or warranties
set forth in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will
be considered an Event of default under Section 3.4 of the Note.

 

4.
           COVENANTS.

 

a.
    Best Efforts.  The parties shall use their commercially reasonable best efforts to satisfy timely each of the conditions
described in Section 6 and 7 of this Agreement.

 

b.

    Use of Proceeds. The Company shall use the proceeds from the sale of the Note for working capital and other general corporate
purposes and shall not, directly or indirectly, use such proceeds for any loan to or investment in any other corporation, partnership,
enterprise or other person (except in connection with its currently existing direct or indirect Subsidiaries).

 

c.
    Expenses.
At the Closing, the Company hereby authorizes the Buyer, as detailed in the disbursement memorandum of even date, to pay the
Buyer’s legal counsel directly in the amount of $5,000, which such amount shall be withheld from the proceeds relating
to the first tranche of $230,000, as further described in the Note and disbursement memorandum.

 

    	 	13	 

     

    

 

d.

    Financial Information. The Company agrees to send or make available the following reports to the Buyer until the Buyer
transfers, assigns, or sells all of the Securities: (i) within ten (10) days after the filing with the SEC, a copy of its Annual
Report on Form 10-K its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K; (ii) within one (1) day after release,
copies of all press releases issued by the Company or any of its Subsidiaries; and (iii) contemporaneously with the making available
or giving to the shareholders of the Company, copies of any notices or other information the Company makes available or gives
to such shareholders. For the avoidance of doubt, filing the documents required in (i) above via EDGAR or releasing any documents
set forth in (ii) above via a recognized wire service shall satisfy the delivery requirements of this Section 4(f).

 

e.

    Listing.  The Company shall promptly secure the listing of the Conversion Shares upon each national securities exchange
or automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance)
and, so long as the Buyer owns any of the Securities, shall maintain, so long as any other shares of Common Stock shall be so
listed, such listing of all Conversion Shares from time to time issuable upon conversion of the Note. The Company will obtain
and, so long as the Buyer owns any of the Securities, maintain the listing and trading of its Common Stock on the OTCBB, OTCQB,
OTC Pink or any equivalent replacement exchange, the Nasdaq National Market (“Nasdaq”), the Nasdaq SmallCap Market
(“Nasdaq SmallCap”), the New York Stock Exchange (“NYSE”), or the NYSE MKT and will comply in all respects
with the Company’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry Regulatory
Authority (“FINRA”) and such exchanges, as applicable. The Company shall promptly provide to the Buyer copies of any
material notices it receives from the OTCBB, OTCQB and any other exchanges or quotation systems on which the Common Stock is then
listed regarding the continued eligibility of the Common Stock for listing on such exchanges and quotation systems.

 

f.

    Corporate Existence.  So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence
and shall not sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or
sale of all or substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i)
assumes the Company’s obligations hereunder and under the agreements and instruments entered into in connection herewith
and (ii) is a publicly traded corporation whose Common Stock is listed for trading on the OTCBB, OTCQB, OTC Pink, Nasdaq, NasdaqSmallCap,
NYSE or AMEX.

 

g.
    No
Integration. The Company shall not make any offers or sales of any security (other than the Securities) under
circumstances that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause
the offering of the Securities to be integrated with any other offering of securities by the Company for the purpose
of any stockholder approval provision applicable to the Company or its securities.

 

    	 	14	 

     

    

 

h.
    Failure to Comply with the 1934 Act. So long as the Buyer beneficially owns the Note, the Company
shall comply with the reporting requirements of the 1934 Act; and the Company shall continue to be subject to the reporting requirements
of the 1934 Act.

 

i.

     Trading Activities.  Neither the Buyer nor its affiliates has an open short position (or other hedging or similar transactions)
in the common stock of the Company and the Buyer agree that it shall not, and that it will cause its affiliates not to, engage
in any short sales of or hedging transactions with respect to the common stock of the Company.

 

j.
    
 Breach of Covenants.  If the Company breaches any of the covenants set forth in this Section 4, and in addition to any
other remedies available to the Buyer pursuant to this Agreement, it will be considered an event of default under Section 3.3
of the Note.

 

5.
           Transfer Agent Instructions. Prior to registration
of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to Rule 144 without
any restriction as to the number of Securities as of a particular date that can then be immediately sold, all such certificates
shall bear the restrictive legend specified in Section 2(g) of this Agreement. The Company warrants that: (i) no stop transfer
instructions to give effect to Section 2(f) hereof (in the case of the Conversion Shares, prior to registration of the Conversion
Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to Rule 144 without any restriction
as to the number of Securities as of a particular date that can then be immediately sold), will be given by the Company to its
transfer agent and that the Securities shall otherwise be freely transferable on the books and records of the Company as and to
the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to transfer or delay, impair,
and/or hinder its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for Conversion
Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when required by the Note and this
Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders
its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on
any certificate for any Conversion Shares issued to the Buyer upon conversion of or otherwise pursuant to the Note as and when
required by the Note and this Agreement. Nothing in this Section shall affect in any way the Buyer’s obligations and agreement
set forth in Section 2(g) hereof to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities.
If the Buyer provides the Company, at the cost of the Buyer, with (i) an opinion of counsel in form, substance and scope customary
for opinions in comparable transactions, to the effect that a public sale or transfer of such Securities may be made without registration
under the 1933 Act and such sale or transfer is effected or (ii) the Buyer provides reasonable assurances that the Securities
can be sold pursuant to Rule 144, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly
instruct its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by the Buyer. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm
to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges
that the remedy at law for a breach of its obligations under this Section may be inadequate and agrees, in the event of a breach
or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled, in addition to all other
available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing
economic loss and without any bond or other security being required. 

 

    	 	15	 

     

    

 

6.
            CONDITIONS PRECEDENT TO THE COMPANY’S OBLIGATIONS  TO SELL. The obligation of the Company hereunder to issue and sell the Note to the Buyer at the Closing is
subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided that these conditions
are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a.
    The Buyer shall have executed this Agreement and delivered the same to the Company.

 

b.
    The Buyer shall have delivered the First Tranche Purchase Price in accordance with Section 1(b) above.

 

c.

    The representations and warranties of the  Buyer shall be true and correct in all material respects as of the date when made
and as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific
date), and the Buyer shall  have performed, satisfied  and  complied in  all  material  respects  with  the covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing
Date.

 

d.

    No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this
Agreement.

 

7.
     CONDITIONS PRECEDENT TO THE BUYER’S OBLIGATION TO  PURCHASE. The
obligation of the Buyer hereunder to purchase the Note at the Closing is subject to the satisfaction, at or before the
Closing Date of each of the following conditions, provided that these conditions are for the Buyer’s sole benefit and
may be waived by the Buyer at any time in its sole discretion: 

 

a.

    The Company shall have executed this Agreement and delivered the same to the Buyer.

 

    	 	16	 

     

    

 

b.

    The Company shall have delivered to the Buyer duly executed Note (in such denominations as the Buyer shall request) in
accordance with Section 1(b) above.

 

c.

    The representations and warranties of the Company shall be true and correct in all material respects as of the date when made
and as of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific
date) and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date.
 The Buyer shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as
of the Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer including,
but not limited to certificates with respect to the Company’s Certificate of Incorporation, By-laws and Board of Directors’
resolutions relating to the transactions contemplated hereby.

 

d.

    No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this
Agreement.

 

e.

    No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including
but not limited to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its
1934 Act reporting obligations.

 

f.

    The Common Stock shall have been authorized for quotation on the OTCBB, OTCQB or any similar quotation system and trading in
the Common Stock on the OTCBB, OTCQB or any similar quotation system shall not have been suspended by the SEC or the OTCBB, OTCQB
or any similar quotation system.

 

g.

    The Buyer shall have received an officer’s certificate described in Section 3(c) above, dated as of the Closing
Date.

 

    	 	17	 

     

    

 

8.
           GOVERNING
LAW; MISCELLANEOUS.

 

a.
    Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of Broward County, Florida or in the federal courts
located in the State of Florida. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and
venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or
based upon forum non conveniens. The Company and Buyer waive trial by jury. The prevailing party shall be entitled to
recover from the other party its reasonable attorney's fees and costs. In the event that any provision of this Agreement or
any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law,
then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not
affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal
service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement
or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any other manner permitted by law.

 

b.

   Counterparts; Signatures by Facsimile.  This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts
have been signed by each party and delivered to the other party.  This Agreement, once executed by a party, may be delivered to
the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering
this Agreement.

 

c.

    Headings.  The headings of this Agreement are for convenience of reference only and shall not form part of, or affect
the interpretation of, this Agreement.

 

d.

   Severability.  In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute
or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed
modified to conform with such statute or rule of law.  Any provision hereof which may prove invalid or unenforceable under any
law shall not affect the validity or enforceability of any other provision hereof.

 

e.
   Entire Agreement; Amendments.  This Agreement and the instruments referenced herein contain the entire understanding of
the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither
the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters.  No provision
of this Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

    	 	18	 

     

    

 

f.
    Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in
writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or
certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges
prepaid, or (iv) transmitted by hand delivery, telegram, facsimile, or electronic mail, addressed as set forth below or to
such other address as such party shall have specified most recently by written notice. Any notice or other communication
required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery, delivery by electronic mail, or
delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number
designated below (if delivered on a business day during normal business hours where such notice is to be received), or the
first business day following such delivery (if delivered other than on a business day during normal business hours where such
notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully
prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be:

 

If
to the Company, to:

 

AXIOM
CORP.

380
Vansickle Road, Unit 600

St.
Catharines, ONT L2S 0B5 Canada

E-mail:
tpearson@papernuts.ca

Facsimile:
                                     

 

With
a copy to:

 

Szaferman,
Lakind, Blumstein & Blader, P.c.

Attn:  Gregg Jaclin

101
Grover Mill Road, Suite 200

Lawrenceville,
NJ 08648

 

If
to the Holder, to:

 

Facsimile:
                                     

 

Each
party shall provide notice to the other party of any change in address.

 

g.
    Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without
the prior written consent of the other. Notwithstanding the foregoing, subject to Section 2(f), the Buyer may assign its
rights hereunder to any person that purchases Securities in a private transaction from the Buyer or to any of its
“affiliates,” as that term is defined under the 1934 Act, without the consent of the Company.

 

    	 	19	 

     

    

 

h.

    Third Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

i.

    Survival.  The representations and warranties of the Company and the agreements and covenants set forth in this Agreement
shall survive the closing hereunder. The Company agrees to indemnify and hold harmless the Buyer and all their officers, directors,
employees and agents for loss or damage arising as a result of or related to any breach by the Company of any of its representations,
warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement
of expenses as they are incurred.

 

j.

     Further Assurances.  Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

k.

    No Strict Construction.  The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

l.

   Publicity. The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any
press releases, SEC, OTCQB (or other applicable trading market), or FINRA filings, or any other public statements with respect
to the transactions  contemplated  hereby; provided,  however,  that  the  Company shall  be  entitled, without
the prior approval of the Buyer, to make any press release or SEC, OTCQB (or other applicable trading market) or FINRA filings
with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the
Company in connection with any such press release prior to its release and shall be provided with a copy thereof).

 

m.

   Registration Rights. The Company hereby grants the Buyer the registration rights set forth on Exhibit B hereto, with respect
to the Note and the shares of Common Stock in which the Note is convertible into, so long as the Note is outstanding.

  

    	 	20	 

     

    

 

 

 

 

 

 

 

[
- signature page follows - ]

 

 

 

 

 

 

 

 

    	 	21	 

     

    

 

IN
        WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first
        above written.

 

	AXIOM CORP.	
	 	 	 
	By:	/s/
    Tyler     Pearson	 
	Name:	Tyler
    Pearson	
	Title:	Chief
    Executive Officer	
	 	 
	
	 	 	 
	 	 	 
	By:	 	 
	Name:		
	Title:		

 

AGGREGATE
    SUBSCRIPTION AMOUNT:

 

	Aggregate
    Principal Amount of Note:	 	 	US$556,250	 
	 	 	 	 	 
	Aggregate
    Purchase Price:	 	 	US$530,000	*

 

*Only
$230,000 of the $530,000 purchase price shall be paid upon full execution of this Agreement. Additional tranches shall be funded
by the Buyer in accordance with the terms of the Note.

 

    	 	22	 

     

    

 

EXHIBIT
A

(see attached)

 

    	 	23	 

     

    

 

EXHIBIT
B REGISTRATION RIGHTS

 

AGREEMENT

 

This
REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of October 5, 2015 (the “Execution
Date”), is entered into by and between AXIOM CORP., a Colorado corporation, with headquarters located at 380
Vansickle Road, Unit 600, St. Catharines, ONT L2S 0B5 Canada (the “Company”), and ________________, a
__________________ company, with its address at _______________________(the “Investor”).

 

RECITALS

 

A.       
 Pursuant to the securities purchase agreement entered into by and between the Company and the Investor of this even date (the
“Securities Purchase Agreement”), the Company has agreed to issue and sell to the Investor, a 10% convertible
note in the aggregate principal amount of US$556,250.00 (the “Note”), which is convertible into an indeterminate
number of shares of the Company’s common stock (the “Common Stock”);

 

B.
       As an inducement to the Investor to execute and deliver the Securities Purchase Agreement, the Company has agreed to provide certain
registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the “1933 Act”), and applicable state securities laws, with respect to the shares of
Common Stock issuable pursuant to the conversion of the Note.

 

C.
       NOW THEREFORE, in consideration of the foregoing promises and the mutual covenants contained hereinafter and other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby
agree as follows:

 

SECTION
1

DEFINITIONS

 

1.1      

As  used  in  this  Agreement,  the  following  terms  shall  have  the  following meanings:

 

“Execution
Date” shall have the meaning set forth in the preambles.

 

“Investor” shall have the meaning set forth
in the preambles.

 

“Person”
means a corporation, a limited liability company, an association, a partnership, an organization, a business, an individual, a
governmental or political subdivision thereof or a governmental agency.

 

    	 	24	 

     

    

 

“Potential
Material Event” means any of the following: (i) the possession by the Company of material information not ripe for disclosure
in the Registration Statement, which shall be evidenced by determinations in good faith by the Board of Directors of the Company
that disclosure of such information in the Registration Statement would be detrimental to the business and affairs of the Company,
or (ii) any material engagement or activity by the Company which would, in the good faith determination of the Board of Directors
of the Company, be adversely affected by disclosure in the Registration Statement at such time, which determination shall be accompanied
by a good faith determination by the Board of Directors of the Company that the Registration Statement would be materially misleading
absent the inclusion of such information.

 

“Register,”
“Registered,” and “Registration” refer to the Registration effected by preparing and filing
one (1) or more Registration Statements in compliance with the 1933 Act and pursuant to Rule 415 under the 1933 Act or any successor
rule providing for offering securities on a continuous basis (“Rule 415”), and the declaration or ordering of effectiveness
of such Registration  Statement(s)  by the  United  States  Securities  and  Exchange  Commission  (the “SEC”).

 

“Registrable
Securities” means (i) all shares of Common Stock issued or issuable pursuant to the Note, and (ii) any shares of capital
stock issued or issuable with respect to such shares of Common Stock, if any, as a result of any stock split, stock dividend,
recapitalization, exchange or similar event or otherwise, which have not been (x) included in the Registration Statement that
has been declared effective by the SEC, or (y) sold under circumstances meeting all of the applicable conditions of Rule 144 (or
any similar provision then in force) under the 1933 Act.

 

“Registration
Statement” means the registration statement of the Company filed under the 1933 Act covering the Registrable
Securities.

 

“Transaction
Documents” shall mean this Agreement and the Securities Purchase Agreement between the Company and the Investor as of
the date hereof, and any other agreements between the Company and the Investor executed in conjunction with this transaction

 

All
capitalized terms used in this Agreement and not otherwise defined herein shall have the same meaning ascribed to them as in the
Securities Purchase Agreement.

  

SECTION
2

REGISTRATION

 

2.1
      The Company shall use all commercially reasonable efforts to, within thirty (30) days of the date of this Agreement, file
with the SEC a Registration Statement or Registration Statements (as is necessary) on Form S-1 (or, if such form is
unavailable for such a registration, on such other form as is available for such registration), covering the resale by the
Investor of all Registrable Securities (the “Registration Amount”), and such Registration Statement(s)
shall state that, in accordance with Rule 416 promulgated under the 1933 Act, that such Registration Statement also
covers such indeterminate number of additional shares of Common Stock as may become issuable upon stock splits, stock
dividends or similar transactions.

 

    	 	25	 

     

    

 

2.2       The
Company shall use all commercially reasonable efforts to have the Registration Statement(s) declared effective by the
SEC.

 

2.3       The Company agrees not to include any other securities in the Registration Statement covering the Registrable Securities without
Investor’s prior written consent, which Investor may unreasonably withhold. Furthermore, the Company agrees that it will
not file any other Registration Statement for other securities, until one hundred and eighty calendar days after the  Registration
 Statement  for  the  Registrable  Securities  is  declared  effective  by the  SEC, without Investor’s prior written consent
which Investor may withhold in its sole discretion.

 

2.4
      Notwithstanding the registration obligations set forth in this Section 2.1, if the staff of the SEC (the “Staff”)
or the SEC informs the Company that all of the unregistered Registrable Securities cannot, as a result of the application of Rule
415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to promptly (i) inform
Investor of such fact and use its commercially reasonable efforts to file amendments to the  Registration  Statement  as  required
 by the  SEC  and/or  (ii)  withdraw  the  Registration Statement and file a new registration statement (the “New Registration
Statement”), in either case covering the maximum number of Registrable Securities permitted to be registered by the
SEC, on Form S-1 to register for resale the Registrable Securities as a secondary offering. If the Company amends the Registration
Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its
commercially reasonable efforts to file with the SEC, as promptly as allowed by the Staff or SEC, one or more registration statements
on Form S-1 to register for resale those Registrable Securities that were not registered for resale on the Registration Statement,
as amended, or the New Registration Statement (each, an “Additional Registration Statement”). Additionally,
the Company shall have the ability to file one or more New Registration Statements to cover the Registrable Securities once the
shares under the initial Registration Statement referenced in Section 2.1 have been sold.

 

SECTION
3

RELATED
OBLIGATIONS

 

At
such time as the Company is obligated to prepare and file the Registration Statement with the SEC pursuant to Section 2, the Company
will affect the registration of the Registrable Securities in accordance  with the intended method of disposition thereof and,
with respect thereto, the Company shall have the following obligations:

 

    	 	26	 

     

    

 

3.1      

The Company shall use all commercially reasonable efforts to cause such Registration Statement relating to the Registrable
Securities to become effective and shall keep such Registration Statement effective until the earlier to occur of the date on
which (A) the Investor shall have sold all the Registrable Securities; or (B) the Investor has no right to acquire any
additional shares of Common Stock under the Securities Purchase Agreement (the “Registration Period”). The
Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make
the statements therein, in light of the circumstances in which they were made, not misleading. The Company shall use all
commercially reasonable efforts to respond to all SEC comments within ten (10) business days from receipt of such comments by
the Company. The Company shall use all commercially reasonable efforts to cause the Registration Statement relating to the
Registrable Securities to become effective no later than two (2) business days after notice from the SEC that the
Registration Statement may be declared effective. The Investor agrees to provide all information which is required by law to
provide to the Company, including the intended method of disposition of the Registrable Securities, and the Company’s
obligations set forth above shall be conditioned on the receipt of such information.

 

3.2
      The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to the Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to
Rule 424 promulgated under the 1933 Act, as may be necessary to keep such Registration Statement effective during the Registration
Period, and, during such period, comply with the provisions of the 1933 Act with respect to the disposition of all Registrable
Securities of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have
been disposed of in accordance with the intended methods of disposition by the Investor thereof as set forth in such Registration
Statement. In the event the number of shares of Common Stock covered by the Registration Statement filed pursuant to this Agreement
is at any time insufficient to cover all of the Registrable Securities, the Company shall amend such Registration  Statement,
 or file a new Registration  Statement  (on the short  form  available therefor, if applicable), or both, so as to cover all of
the Registrable Securities, in each case, as soon as practicable, but in any event within thirty (30) calendar days after the
necessity therefor arises. The Company shall use commercially reasonable efforts to cause such amendment and/or new Registration
Statement to become effective as soon as practicable following the filing thereof.

 

3.3
     The Company shall make available to the Investor whose Registrable Securities are included in any Registration Statement and
its legal counsel without charge (i) promptly after the same is prepared and filed with the SEC at least one (1) copy of such
Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated
therein by reference and all exhibits, the prospectus included in such Registration Statement (including each preliminary
prospectus) and, with regards to such Registration Statement(s), any correspondence by or on behalf of the Company to the SEC
or the staff of the SEC and any correspondence from the SEC or the staff of the SEC to the Company or its representatives;
(ii) upon the effectiveness of any Registration Statement, the Company shall make available copies of the prospectus, via
EDGAR, included in such Registration Statement and all amendments and supplements thereto; and (iii) such other documents,
including copies of any preliminary or final prospectus, as the Investor may reasonably request from time to time to
facilitate the disposition of the Registrable Securities.

 

    	 	27	 

     

    

 

3.4

      The Company shall use  commercially reasonable efforts to (i) register  and qualify the Registrable Securities covered by the
Registration Statement under such other securities or “blue sky” laws of such states in the United States as the Investor
reasonably requests; (ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements
to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period;
(iii) take such other actions as may be necessary to maintain such registrations and qualifications in effect at all times during
the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities
for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition
thereto to (A) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section
3.4, or (B) subject itself to general taxation in any such jurisdiction. The Company shall promptly notify the Investor who holds
Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration or
qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any jurisdiction
in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

3.5
      As promptly as practicable after becoming aware of such event, the Company shall notify
Investor in writing of the happening of any event as a result of which the prospectus included in the Registration Statement,
as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading
(“Registration Default”) and use all diligent efforts to promptly prepare a supplement or amendment to
such Registration Statement and take any other necessary steps to cure the Registration Default (which, if such Registration
Statement is on Form S-3, may consist of a document to be filed by the Company with the SEC pursuant to Section 13(a), 13(c),
14 or 15(d) of the 1934 Act (as defined below) and to be incorporated by reference in the prospectus) to correct such untrue
statement or omission, and make available copies of such supplement or amendment to the Investor. The Company shall also
promptly notify the Investor (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed,
and when the Registration Statement or any post-effective amendment has become effective (the Company will prepare
notification of such effectiveness which shall be delivered to the Investor on the same day of such effectiveness and by
overnight mail), additionally, the Company will promptly provide to the Investor, a copy of the effectiveness order prepared
by the SEC once it is received by the Company; (ii) of any request by the SEC for amendments or supplements to the
Registration Statement or related prospectus or related information, (iii) of the Company’s reasonable determination
that a post-effective amendment to the Registration Statement would be appropriate, (iv) in the event the
Registration Statement is no longer effective, or (v) if the Registration Statement is stale as a result of the
Company’s failure to timely file its financials or otherwise

      

    	 	28	 

     

    

 

3.6

      The  Company shall  use  all  commercially reasonable  efforts  to  prevent  the issuance of any stop order or other suspension
of effectiveness of the Registration Statement, or the suspension of the qualification of any of the Registrable Securities for
sale in any jurisdiction and,  if  such  an  order  or  suspension  is  issued,  to  obtain the  withdrawal  of  such  order
or suspension at the earliest possible moment and to notify the Investor holding Registrable Securities being sold of the issuance
of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding concerning
the effectiveness of the registration statement.

 

3.7

      The Company shall permit the Investor and one (1) legal counsel, designated by the Investor, to review and comment upon the Registration
Statement and all amendments and supplements thereto at the request of the Investor. However, any postponement of a filing of
a Registration Statement or any postponement of a request for acceleration or any postponement of the effective date or effectiveness
of a Registration Statement by written request of the Investor (collectively, the “Investor’s Delay”)
shall not act to trigger any penalty of any kind, or any cash amount due or any in-kind amount due the Investor from the Company
under any and all agreements of any nature or kind between the Company and the Investor. The event(s) of an Investor’s Delay
shall act to suspend all obligations of any kind or nature of the Company under any and all agreements of any nature or kind between
the Company and the Investor.

 

3.8

     At the request of the  Investor, the Company’s  counsel shall furnish to the Investor an opinion letter confirming the effectiveness
of the registration statement and the free trading status of the Registrable Securities. Such opinion letter shall be issued as
of the date of the effectiveness of the registration statement and be in a form reasonably acceptable to the Investor, Company’s
transfer agent, and Investor’s broker(s).

 

3.9

      The  Company  shall  hold  in  confidence  and  not  make  any  disclosure  of information concerning the Investor unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information
is ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction,
or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement
or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information  concerning  the
Investor  is  sought  in  or  by a  court  or  governmental  body of competent jurisdiction or through other means, give prompt
written notice to the Investor and allow the  Investor,  at  the  Investor’s expense,  to undertake  appropriate action
to prevent disclosure of, or to obtain a protective order covering such information.

 

    	 	29	 

     

    

 

3.10

    The Company shall use all commercially reasonable efforts to maintain designation and quotation of all the Registrable Securities
covered by any Registration Statement on the principal market in which the Company’s common stock is then traded. If, despite
the Company’s commercially reasonable efforts, the Company is unsuccessful in satisfying the preceding sentence, it shall
use commercially reasonable efforts to cause all the Registrable Securities covered by any Registration Statement to be listed
on each other national securities exchange and automated quotation system, if any, on which securities of the same class or series
issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules
of such exchange or system. The Company shall pay all fees and expenses in connection with satisfying its obligation under this
Section 3.10.

 

3.11

    The Company shall cooperate with the Investor to facilitate electronic delivery of the Registrable Securities or if requested
by the Investor, the preparation of certificates to be offered pursuant to the Registration Statement and enable such certificates
to be in such denominations or amounts, as the case may be, as the Investor may reasonably request and after any sales of such
Registrable Securities by the Investor, such certificates not bearing any restrictive legend).

 

3.12

    The Company shall provide a transfer agent for all the Registrable Securities not later than the effective date of the first Registration
Statement filed pursuant hereto.

 

3.13     If  requested  by the  Investor,  the  Company shall  (i)  as  soon  as  reasonably practical incorporate in a prospectus supplement
or post-effective amendment such information as the Investor reasonably determines should be included therein relating to the
sale and distribution of Registrable Securities, including, without limitation, information with respect to the offering of the
Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective
amendment as soon as reasonably possible after being notified of the matters to be incorporated in such prospectus supplement
or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement if reasonably requested by
the Investor.

 

3.14

    The  Company  shall  use  all  commercially  reasonable  efforts  to  cause  the Registrable Securities covered by the applicable
Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be necessary
to facilitate the disposition of such Registrable Securities.

 

3.15

    The Company shall otherwise use all commercially reasonable efforts to comply with  all  applicable  rules  and  regulations
of  the  SEC  in  connection  with  any registration hereunder.

 

3.16

    Within two (2) business day after the Registration Statement which includes Registrable Securities is declared effective by the
SEC, the Company shall deliver to the transfer agent for such Registrable Securities, with copies to the Investor, confirmation
that such Registration Statement has been declared effective by the SEC.

 

    	 	30	 

     

    

 

3.17

    The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable
Securities pursuant to the Registration Statement.

 

SECTION
4

OBLIGATIONS
OF THE INVESTOR

 

4.1

     At least five (5) calendar days prior to the first anticipated filing date of the Registration Statement the Company shall notify
the Investor in writing of the information the Company requires from the Investor for the Registration Statement. It shall be
a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to
the Registrable Securities and the Investor agrees to furnish to the Company that information regarding itself, the Registrable
Securities and the intended method of disposition of the Registrable Securities as shall reasonably be required to effect the
registration of such Registrable Securities and the Investor shall execute such documents in connection with such registration
as the Company may reasonably request.

 

4.2

     The Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by
the Company in connection with the preparation and filing of any Registration Statement hereunder.

 

4.3

      The Investor agrees that, upon receipt of written notice from the Company of the happening of any event of the kind described
in Section 3.6 or the first sentence of 3.5, the Investor will immediately discontinue disposition of Registrable Securities pursuant
to any Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the
supplemented or amended prospectus contemplated by Section 3.6 or the first sentence of 3.5.

 

SECTION
5

EXPENSES
OF REGISTRATION

 

All
legal expenses, other as set forth in the Securities Purchase Agreement, incurred in connection with registrations including comments,
filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications
fees, and printing fees shall be paid by the Company.

 

    	 	31	 

     

    

  

SECTION
6

INDEMNIFICATION

 

In
the event any Registrable Securities are included in the Registration Statement under this Agreement:

 

6.1

      To the fullest extent permitted by law, the Company, under this Agreement, will, and hereby does, indemnify, hold harmless
and defend the Investor who holds Registrable Securities, the directors, officers, partners, employees, counsel, agents,
representatives of, and each Person, if any, who controls, any Investor within the meaning of the 1933 Act or the Securities
Exchange Act of 1934, as amended (the “1934 Act”) (each, an “Indemnified Person”),
against any losses, claims, damages, liabilities, judgments, fines, penalties, charges, costs, attorneys’ fees, amounts
paid in settlement or expenses, joint or several (collectively, “Claims”), incurred in investigating,
preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or
before any court or governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened,
whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”), to which any of
them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in the
Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of
the offering under the securities or other “blue sky” laws of any jurisdiction in which the Investor has
requested in writing that the Company register or qualify the Shares (“Blue Sky Filing”), or the omission
or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which the statements therein were made, not misleading, (ii) any untrue statement or alleged
untrue statement of a material fact contained in the final prospectus (as amended or supplemented, if the Company files any
amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any material fact
necessary to make the statements made therein, in light of the circumstances under which the statements therein were made,
not misleading, or (iii) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any other law,
including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or
sale of the Registrable Securities pursuant to the Registration Statement (the matters in the foregoing clauses (i) through
(iii) being, collectively, “Violations”). Subject to the restrictions set forth in Section 6.3 the Company
shall reimburse the Investor and each such controlling person, promptly as such expenses are incurred and are due and
payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or
defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained
in this Section 6.1: (i) shall not apply to a Claim arising out of or based upon a Violation which is due to the inclusion in
the Registration Statement of the information furnished to the Company by any Indemnified Person expressly for use in
connection with the preparation of the Registration Statement or any such amendment thereof or supplement thereto; (ii) shall
not be available to the extent such Claim is based on (a) a failure of the Investor to deliver or to cause to be delivered
the prospectus made available by the Company or (b) the Indemnified Person’s use of an incorrect prospectus despite
being promptly advised in advance by the Company in writing not to use such incorrect prospectus; (iii) any claims based on
the manner of sale of the Registrable Securities by the Investor or of the Investor’s failure to register as a dealer
under applicable securities laws; (iv) any omission of the Investor to notify the Company of any material fact that should be
stated in the Registration Statement or prospectus relating to the Investor or the manner of sale; and (v) any amounts
paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which
consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless of any
investigation made by or on behalf of the Indemnified Person and shall survive the resale of the Registrable Securities by
the Investor pursuant to the Registration Statement.

 

    	 	32	 

     

    

 

6.2

     In connection with any Registration Statement in which Investor is participating, the Investor agrees to severally and
jointly indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6.1, the
Company, each of its directors, each of its officers who signs the Registration Statement, each Person, if any, who controls
the Company within the meaning of the 1933 Act or the 1934 Act and the Company’s agents (collectively and together with
an Indemnified Person, an “Indemnified Party”), against any Claim or Indemnified Damages to which any of
them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise
out of or are based upon any Violation, in each case to the extent, and only to the extent, that such Violation is due to the
inclusion in the Registration Statement of the written information furnished to the Company by the Investor expressly for use
in connection with such Registration Statement; and, subject to Section 6.3, the Investor will reimburse any legal or other
expenses reasonably incurred by them in connection with investigating or defending any such Claim; provided, however,
that the indemnity agreement contained in this Section 6.2 and the agreement with respect to contribution contained in
Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written
consent of the Investor, which consent shall not be unreasonably withheld; provided, further, however, that the Investor
shall only be liable under this Section 6.2 for that amount of a Claim or Indemnified Damages as does not exceed the net
proceeds to such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified
Party and shall survive the resale of the Registrable Securities by the Investor pursuant to the Registration Statement.
Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6.2 with
respect to any preliminary prospectus shall not inure to the benefit of any Indemnified Party if the untrue statement or
omission of material fact contained in the preliminary prospectus were corrected on a timely basis in the prospectus, as then
amended or supplemented. This indemnification provision shall apply separately to each Investor and liability hereunder shall
not be joint and several.

 

    	 	33	 

     

    

 

6.3

      Promptly after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of
any action or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or
Indemnified Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the
right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying
party and the Indemnified Person or the Indemnified Party, as the case may be; provided, however, that an Indemnified Person
or Indemnified Party shall have the right to retain its own counsel with the fees and expenses to be paid by the indemnifying
party, if, in the reasonable opinion of counsel retained by the Indemnified Person or Indemnified Party, the representation
by counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or
potential differing interests between such Indemnified Person or Indemnified Party and any other party represented by such
counsel in such proceeding. The indemnifying party shall pay for only one (1) separate legal counsel for the Indemnified
Persons or the Indemnified Parties, as applicable, and such counsel shall be selected by the Investor, if the Investor is
entitled to indemnification hereunder, or the Company, if the Company is entitled to indemnification hereunder, as
applicable. The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with
any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party
all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or Claim.
The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times as to the status of
the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of
any action, claim or proceeding affected without its written consent, provided, however, that the indemnifying party shall
not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the consent of the
Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise
which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or
Indemnified Person of a release from all liability in respect to such Claim. Following indemnification as provided for
hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with
respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The
failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action
shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this Section
6, except to the extent that the indemnifying party is prejudiced in its ability to defend such action.

 

6.4

      The indemnity agreements contained herein shall be in addition to (i) any cause of  action  or  similar  right  of  the  Indemnified
 Party or  Indemnified  Person  against  the indemnifying party or others, and (ii) any liabilities the indemnifying party may
be subject to pursuant to the law.

 

    	 	34	 

     

    

 

SECTION
7

CONTRIBUTION

 

7.1

      To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to
make the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the
fullest extent permitted by law; provided, however, that: (i) no contribution shall be made under circumstances where
the maker would not have been liable for indemnification under the fault standards set forth in Section 6; (ii) no seller of
Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be
entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and
(iii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds received
by such seller from the sale of such Registrable Securities. Notwithstanding the provisions of this Section, no Investor
shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually
received by such Investor from the applicable sale of the Registrable Securities subject to the claim exceeds the amount of
any damages that such Investor has otherwise been required to pay, or would otherwise be required to pay under Section 6.2,
by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

SECTION
8

REPORTS
UNDER THE 1934 ACT

 

8.1

      With a view to making available to the Investor the benefits of Rule 144 promulgated under the 1933 Act or any other similar
rule or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without
registration (“Rule 144”), provided that the Investor holds any Registrable Securities are eligible for resale under
Rule 144, the Company agrees to:

 

(a)

      make and keep public information available, as those terms are understood and defined in Rule 144;

 

(b)

      file with the SEC in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934
Act so long as the Company remains subject to such requirements (it being understood that nothing herein shall limit the Company’s
obligations under Section 5(c) of the Securities Purchase Agreement) and the filing of such reports and other documents is required
for the applicable provisions of Rule 144; and

 

(c)

      furnish to the Investor, promptly upon request, (i) a written statement by the Company that it has complied with the reporting
requirements of Rule 144, the 1933 Act and the 1934 Act, (ii) a copy of the most recent annual or quarterly report of the Company
and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested
to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

    	 	35	 

     

    

 

SECTION
9

MISCELLANEOUS

 

9.1

     Notices. Any notices or other communications required or permitted to be given under the terms of this Agreement must be
given in accordance with the Securities Purchase Agreement.

 

9.2
 

      No Waivers. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party
in exercising such right or remedy, shall not operate as a waiver thereof.

 

9.3
 

      No Assignments. The rights and obligations under this Agreement shall not be assignable.

 

9.4
 

     Entire Agreement/Amendment.  This  Agreement  and  the  Transaction Documents constitute the entire agreement among the
parties hereto with respect to the subject matter hereof and thereof. There are no restrictions, promises, warranties or undertakings,
other than those set forth or referred to herein and therein. This Agreement and the Transaction Documents supersede all prior
agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof. The provisions of
this Agreement may be amended only with the written consent of the Company and Investor.

 

9.5

     Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect
the meaning hereof. Whenever required by the context of this Agreement, the singular shall include the plural and masculine shall
include the feminine. This Agreement shall not be construed as if it had been prepared by one of the parties, but rather as if
all the parties had prepared the same.

 

9.6

     Counterparts. This Agreement may be executed in any number of counterparts and  by the  different  signatories  hereto
 on  separate  counterparts,  each  of  which,  when  so executed, shall be deemed an original, but all such counterparts shall
constitute but one and the same instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature
or other similar electronic means with the same force and effect as if such signature page were an original thereof.

 

9.7

      Further assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

9.8

     Severability.
In case any provision of this Agreement is held by a court of competent jurisdiction to be excessive in scope or otherwise
invalid or unenforceable, such provision shall be adjusted rather than voided, if possible, so that it is
enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Agreement
will not in any way be affected or impaired thereby.

 

    	 	36	 

     

    

 

9.9

      Law  governing  this  agreement.  This  Agreement  shall  be  governed  by  and construed in accordance with the laws of
the State of Florida without regard to principles of conflicts  of  laws.  Any  action  brought  by  either  party  against  the
 other  concerning  the transactions contemplated by this Agreement shall be brought only in the state courts of Florida or in
the federal courts located in Broward County, Florida. The parties to this Agreement hereby irrevocably waive any objection to
jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue
or based upon forum non conveniens. The parties executing this Agreement and other agreements referred to herein
or delivered in connection herewith on behalf of the Company agree to submit to the in personam jurisdiction of such courts and
hereby irrevocably waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable
attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection
herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative
to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such
provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other
provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being served
in any suit, action or proceeding in connection with this Agreement or any other Transaction Documents by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law.

 

9.10

    No third party beneficiaries. This Agreement is intended for the benefit of the parties hereto and is not for the benefit
of, nor may any provision hereof be enforced by, any other person, except that the Company acknowledges that the rights of the
Investor may be enforced by its general partner.

 

(Signature
page immediately follows)

 

    	 	37	 

     

    

  

        IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed by their respective authorized representatives
as of the Execution Date.

         

	AXIOM CORP.	
	 	 	 
	By:	/s/
    Tyler     Pearson	 
	Name:	Tyler
    Pearson	
	Title:	Chief
    Executive Officer	
	 	 
	
	 	 	 
	 	 	 
	By:	 	 
	Name:		
	Title:		

 

 

38Exhibit 10.10

 

Carter,
Terry & Company.

3060 Peachtree Rd, Suite 1200,

Atlanta GA 30305

Phone: 404-364-3070-Member FINRA SIPC

  

May 26, 2015

 

Tyler Pearson

Axiom Corp

380 Vansickle Road

Unit 600

St. Catherines, ON L2S 0B5

 

Subject: Private Placement Offering for
Axiom Corp (AXMM.OB)

 

It is our understanding
that Axiom Corp, the “Company”, desires to raise capital, as well as to fund the Company’s continuing general
operations. Based on our discussions, our preliminary review of the financial information submitted to Carter, Terry & Company.,
referred heretofore as the (“AGENT”) and representations you and your associates have made to us with regard to the
present and proposed business activities of the Company, its operations and financial condition, we would like to confirm our
interest in acting as the Company’s exclusive Financial Advisor Investment Bank and Placement Agent, on a "best efforts"
basis.. In such role we would assist the Company in one or more capital raises which might result in a private placement, merger,
acquisition, sale of assets, sale of common stock, sale of ownership interest or any other financial transaction hereinafter referred
to as a "Transaction" upon the basic terms and conditions set forth herein (the "Agreement"), as well as a
full array of additional investment banking services.

 

Section I: Services to
be rendered

 

“AGENT” services will include
(but not be limited to) the following:

 

		(i)	Arranging
                                         for one or more institutional investments of capital, as defined in iii, (an “Investment,”
                                         which could include any variation thereof, including common stock, preferred stock, mezzanine
                                         debt, senior secured debt, any other financial instrument or a combination of several
                                         financial instruments), on a best efforts basis (in a form and on terms satisfactory,
                                         in its sole judgment, to the Company) to raise capital for use by the Company;

 

		(ii)	Any
                                         Investment will be placed in compliance with valid exemptions from registration or qualification
                                         under federal securities laws, state securities (“blue sky”) laws or foreign
                                         securities laws of each jurisdiction in which any offers of an Investment may be made;

 

		(iii)	Utilizing
                                         appropriate investment information materials or modifying existing Company business plans
                                         and documents (collectively, the “Information Memorandum”) to be provided
                                         to potential sources of financing. “AGENT” will provide advice with respect
                                         to negotiating with all potential financing, merger or acquisition candidates introduced
                                         (as defined in Section II below) to the Company by “AGENT” (as defined below;
                                         any such identified and introduced candidates, along with their affiliates, associates,
                                         subsidiaries, divisions and related entities being hereinafter referred to as “Investor
                                         Candidates”) who might be interested or involved in making an Investment in the
                                         Company, including reviewing the preliminary and final documentation relating to any
                                         such financing. As used herein, “Investor Candidates” shall mean and include
                                         individual, strategic and institutional investors of all types, introduced (as defined
                                         in Section II below) to the Company by “AGENT” including individuals, trusts,
                                         estates, partnerships and associations, banks, thrifts, insurance companies and other
                                         financial institutions, investment companies and other pooled investment vehicles, all
                                         tax-exempt organizations such as those subject to ERISA and other public and private
                                         pension funds, endowments and foundations as well as corporations in similar lines of
                                         business to the Company’s, which might be candidates for acquisition by or merger
                                         with , together with their affiliates, divisions, subsidiaries and investment management
                                         consultants. All Investor Candidates, if not merger or acquisition candidates, shall
                                         be “accredited investors,” as that term is generally understood in the private
                                         equity business;

 

    	 	1

     

    

 

In performing services
hereunder, “AGENT” shall be regarded as an independent contractor and marketing representative. “AGENT”
shall not have any right or authority to create any obligations of any kind on behalf of the Company, shall make no representation
to any third party to the contrary, and shall not make any representations about the Company, its operations or finances other
than what the Company provides for inclusion in the Information Memorandum. Nothing contained in this Agreement shall be
deemed or construed to create a partnership or joint venture between Company and “AGENT” or between Company and any
Investor Candidate.

 

Section II: Fees, Expenses and Term

 

“AGENT” will
be the exclusive financial advisor to and representative of the Company for an initial period of 30 days, and then reverting to
a non-exclusive financial advisor for the next twelve consecutive (12) months commencing on the date of this Agreement, with an
option to extend this Agreement an additional 6 months, provided however, that either party may withdraw from this Agreement at
any time upon written notice to the other party. Otherwise, this engagement and the terms hereunder will continue, subject to
the same right of either party to terminate on written notice to the other party, until a Transaction is successfully completed
or until the Agreement is terminated. Within three business days after the effective date of any termination by the Company (the
"Termination Date"), “AGENT” shall deliver to Company a list of all introduced Investor Candidates, merger
or acquisition candidates and Strategic Investors (the "Covered Parties") with which “AGENT” can confirm
that (a) the Company, at “AGENT’s” instigation or by “AGENTs” introduction, has had discussions
concerning a Transaction during the term of this Agreement and prior to receipt of the notice of termination or (b) such Covered
Parties have, prior to such notice of termination, expressed an interest in considering or pursuing a Transaction with Company.
On and after the Termination Date, “AGENT” shall also either destroy or return to Company any and all Information,
Information Memoranda and any other confidential information of the Company (including extracts thereof), which are in “AGENT’s”
possession or control. The provisions concerning confidentiality, indemnification, compensation and the Company's obligations
to pay fees and reimburse expenses contained herein and the Company's obligations contained in the Indemnification Provisions
(as hereinafter defined) will survive any such termination. “AGENT” agrees not to use any confidential information
about the Company for any purposes other than in connection with a Transaction and directly related matters.

 

The Company will attach
any investor candidate that is considered already engaged with them on APPENDIX A, following the signature page. The company
agrees any investor candidate introduced by “AGENT” not on the list is considered the “AGENT’s”
introduction.

 

“AGENT” agrees
to introduce the Company to certain potential Investor Candidates. Upon written request from the Company, “AGENT”
may designate independent counsel to prepare the appropriate documents (including subscription and escrow agreement) with regard
to the terms of any financial transactions and the closing thereof. The Company is responsible for any and all reasonable expenses
associated with the Offering and the closing documents, escrow and escrow agent. However incurrence of any such expenses over
$2,500.00 shall require the prior written consent for those expenses from the Company.

 

    	 	2

     

    

 

Stock Compensation Fees:

 

Within 5 business days upon the execution of this engagement, the
Company will deliver 100,000, fully paid for and earned, restricted shares of Axiom Corp common stock to Carter Terry & Company.
It will be Carter Terry’s right to designate the distribution of these shares to individuals within the firm at their discretion.
These shares shall maintain piggy-back registration rights. The Company further agrees to approve and provide payment for the
opinion of resale of these shares in the event they have not been registered after 6 months from the anniversary of the execution
of this agreement.

 

If, within the two year
period commencing on the date hereof, the Investor Candidate , singly or with others, purchases debt or equity securities of,
or loans money to the Company, the Company will pay “AGENT” within three business days upon after any such transaction
under the following terms below:

 

	 	(i)	Cash Compensation Fees:

 

A success fee for debt and/or equity capital raised by “AGENT” on behalf of Company
shall be subject to the following fee structure:

 

		a.	10%
                                         of the amount for any equity or hybrid equity capital raised up to $1,000,000

		b.	8%
                                         of the amount for any equity or hybrid equity capital raised up to $5,000,000

		c.	6%
                                         of the amount for any equity or hybrid equity capital raised over $5,000,000

 

		(ii)	A
                                         success fee which shall be the identical terms as in Section II (i) above of the Aggregate
                                         Consideration (except as further defined in (iii) below) received by Company from any
                                         Transaction closed, including multiple successive Transactions, with an Investor Candidate
                                         or a Strategic Candidate (or upon closing a Transaction with a Covered Party, including
                                         multiple successive Transactions, within twelve months after the Termination Date), which
                                         amount will be paid when the Company receives the proceeds from the Transaction.

 

		(iii)	Restricted
                                         Stock:

 

In connection with the compensation
set forth above, the Company agrees to pay “AGENT” amount of restricted shares equal to 4% of capital raised divided
by the closing price of the stock on the date of close. These shares shall have piggy back registration rights. In the event the
shares are not registered within 6 months of the anniversary of this executed engagement, the Company agrees to approve and pay
for the opinion of sale under Rule 144.

 

For purposes of this Agreement,
"introduced" means that “AGENT” shall have brought the prospective Investor Candidate, Strategic Investor
or Transaction (“Investor Candidate”) to the attention of the Company and “AGENT” shall have been a procuring
cause in its consummation of the matter. “Procuring cause” shall mean that “AGENT” shall have identified
the Investor Candidate, the merger or acquisition candidate or the Strategic Investor to Company and conducted initial qualifying
discussions regarding an Investment in or other Transaction with Company, or caused the parties to have attended meetings for
the purpose of considering a Transaction.

 

    	 	3

     

    

 

For purposes of this Agreement,
“Aggregate Consideration” shall mean the total value of all cash, securities, other property and any other consideration,
including, without limitation (as, if and when received), any contingent, earned or other assets or consideration, paid or payable,
directly or indirectly, in connection with the Transaction, net of any indebtedness owed upon the same, it being the intention
of this provision that the Aggregate Consideration shall mean the net equity value of any cash, tangible assets or measurable
intangible assets acquired by, invested in, loaned to or transferred to the Company. If any non-cash consideration is a class
of newly-issued, publicly-traded securities, then the fair market value thereof shall be the average of the closing prices for
the twenty trading days subsequent to the fifth trading day after the consummation of the Transaction. If no public market exists
for any securities issued in the Transaction or a class of securities is not intended to be publicly traded or convertible into
publicly-traded securities, then the fair market value thereof shall be determined by the valuation placed upon these securities
by the parties to the Transaction.

 

Section III: Indemnification

 

The Company agrees to
indemnify and hold “AGENT”, which terms for the purposes of this Agreement include the partners, controlling persons,
officers, employees and agents of “AGENT”, harmless from and against any and all losses, claims, damages, costs, liabilities
or expenses (including reasonable attorney’s fees and expenses), joint or several, to which “AGENT” may become
subject in connection with its performance of the services described herein resulting from Company’s material breach of
this Agreement, gross negligence, willful misconduct or misfeasance, provided, however, that Company shall not be liable in any
such case to the extent that any such loss, claim, damage, liability, cost or expense is found in a final judgment by a court
of law to have directly resulted from the gross negligence or willful misconduct of “AGENT” .

 

Likewise “AGENT”
agrees to indemnify and hold Company, which terms for the purposes of this paragraph include the subsidiaries, partners, controlling
persons, officers, stockholders and employees of Company, harmless from and against any and all losses, claims, damages, costs,
liabilities or expenses (including reasonable attorney’s fees and expenses), joint or several, to which Company may become
subject resulting from “AGENT’s” material breach of this Agreement, gross negligence, willful misconduct or
misfeasance, provided however, that “AGENT” shall not be liable in any such case to the extent that any such loss,
claim, damage, liability, cost or expense is found in a final judgment by a court of law to have directly resulted from the gross
negligence or willful misconduct of Company.

 

Section IV: Other

 

Each party to this Agreement
agrees to keep in strict confidence the proprietary and non-public information of the other party during the term of this Agreement
and thereafter, provided however that the foregoing shall not prohibit disclosures (i) pursuant to the exercise of the parties'
responsibilities under this Agreement; (ii) required by law or legal process (provided notice is given prior to such disclosure);
or (iii) of matters which become public other than by the actions of the disclosing party hereunder.

 

If “AGENT”
completes the Private Placement or any other Transaction pursuant to the Agreement, “AGENT” may, at its own expense,
place an announcement, subject to Company’s prior consent and approval, in any newspapers and periodicals it may select
stating that “AGENT” has acted as financial advisor, investment banker or placement agent for Company in the Transaction.

 

Carter, Terry & Company
is a registered broker dealer, whose address is herein below for to this contemplated transaction.

 

Carter, Terry
& Company.

3060 Peachtree
Rd

Suite 1200

Atlanta, GA
30305

Attention: Mr.
Timothy J. Terry

Telephone: (404)
364-3070

 

    	 	4

     

    

 

This agreement shall be
construed in accordance with the laws of the State of Georgia and the parties agree to submit themselves to the jurisdiction of
the courts located in that state, which shall be the sole tribunals in which either party may institute and maintain a legal proceeding
against the other party arising from any dispute hereunder.

 

If any agreement, covenant,
warranty or other provision of this Agreement is invalid, illegal or incapable of being enforced by reason of any rule of law
or public policy, all other agreements, covenants, warranties and other provisions of this Agreement shall, nevertheless, remain
in full force and effect. No waiver by either party of a breach or non-performance of any provision or obligation of this Agreement
shall be deemed to be a waiver of any preceding or succeeding breach of the same or any other provision of this Agreement. This
Agreement is the entire agreement of the parties with respect to the subject matter hereof, supersedes all prior agreements and
understandings, oral or written, relating to the subject matter hereof, and may not be amended, supplemented, or modified except
by written instrument executed by all parties hereto. Neither party may assign any of its rights or obligations under this Agreement
without the prior written consent of the other party.

 

All notices or other communications
under this Agreement must be in writing and sent by prepaid, first class airmail, delivered by hand or transmitted by facsimile
or email to the email address or facsimile number of the recipient set out below or such other address, email address or facsimile
number as may be furnished in writing by the recipient to the other party. The addresses, email addresses and facsimile numbers
of the parties for purposes of this Agreement are:

 

	Axiom Corp.	Carter, Terry & Company
	380 Vansickle Road	3060 Peachtree Rd
	Suite 600	Suite 1200
	St. Catherines, ON L2S 0B5	Atlanta, GA 30305
	 	 
	Phone: 404-364-3070	Phone:  905-646-8781

 

If the foregoing is acceptable to you, please
indicate your approval by signing in the space provided and returning an executed copy of this Agreement to us.

 

We are very enthusiastic
about working with your team toward the successful completion of this assignment.

 

Understood and agreed, this 26th
day of May, 2015. 

 

	Axiom Corp	 	Carter, Terry & Company.
	 	 	 
	/s/ Tyler Pearson	 	/s/ Timothy J. Terry
	Tyler Pearson - CEO	 	Timothy J. Terry - CEO

 

    	 	5

     

    

 

APPENDIX A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]